# Sierra Oncology Inc. (SRRA)

Source: https://www.quantisnow.com/company/SRRA
Generated: 2026-11-18T04:13:04.039Z

- Ticker: SRRA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2015
- Website: sierraoncology.com

## About

Sierra Oncology, Inc. researches, develops, and commercializes therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally-bioavailable JAK1, JAK2, and ACVR1 inhibitor that has two completed Phase 3 trials for the treatment of myelofibrosis. The company also develops SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1; and SRA141, an orally bioavailable small molecule inhibitor of cell division cycle 7 kinase. The company was formerly known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was incorporated in 2003 and is based in San Mateo, California.

## Latest SRRA news and filings

- 2022-07-18 20:07 UTC [Market Insight] [Codexis Announces CEO Transition Effective August 9, 2022, John Nicols To Retire As President, CEO; Dr. Stephen Dilly Appointed By Board Of Directors](https://www.quantisnow.com/insight/codexis-announces-ceo-transition-effective-august-9-2022-john-nicols-3154138)
- 2022-07-18 20:05 UTC [Leadership Update] [Codexis Announces CEO Transition Effective August 9, 2022](https://www.quantisnow.com/insight/codexis-announces-ceo-transition-effective-august-9-2022-3154078)
- 2022-07-11 20:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Sierra Oncology Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-sierra-oncology-inc-amendment-3128985)
- 2022-07-11 20:01 UTC [SEC Form 15-12G filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-sierra-oncology-inc-3128621)
- 2022-07-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-sierra-oncology-inc-3121012)
- 2022-07-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-sierra-oncology-inc-3121009)
- 2022-07-05 21:06 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Sierra Oncology Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-sierra-oncology-inc-amendment-3108778)
- 2022-07-01 20:59 UTC [SEC Form 4] [SEC Form 4: Vivo Opportunity, Llc returned $183,123,160 worth of shares to the company (3,329,512 units at $55.00)](https://www.quantisnow.com/insight/sec-form-4-vivo-opportunity-llc-returned-183123160-worth-of-3101885)
- 2022-07-01 20:50 UTC [SEC Form 4] [SEC Form 4: Orbimed Advisors Llc returned $108,062,350 worth of shares to the company (1,964,770 units at $55.00)](https://www.quantisnow.com/insight/sec-form-4-orbimed-advisors-llc-returned-108062350-worth-of-3101797)
- 2022-07-01 20:46 UTC [SEC Form 4] [SEC Form 4: Ashiya Mona returned $108,062,350 worth of shares to the company (1,964,770 units at $55.00)](https://www.quantisnow.com/insight/sec-form-4-ashiya-mona-returned-108062350-worth-of-shares-3101776)
- 2022-07-01 20:45 UTC [SEC Form 4] [SEC Form 4: Aggarwal Gaurav returned $150,471,915 worth of shares to the company (2,735,853 units at $55.00)](https://www.quantisnow.com/insight/sec-form-4-aggarwal-gaurav-returned-150471915-worth-of-shares-3101765)
- 2022-07-01 20:44 UTC [SEC Form 4] [SEC Form 4: Sinclair Andrew returned $72,276,985 worth of shares to the company (1,314,127 units at $55.00) (withholding obligation)](https://www.quantisnow.com/insight/sec-form-4-sinclair-andrew-returned-72276985-worth-of-shares-3101761)
- 2022-07-01 20:43 UTC [SEC Form 4] [SEC Form 4: Klencke Barbara returned $825,000 worth of shares to the company (15,000 units at $55.00), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-klencke-barbara-returned-825000-worth-of-shares-3101751)
- 2022-07-01 20:42 UTC [SEC Form 4] [SEC Form 4 filed by Jagpal Sukhi](https://www.quantisnow.com/insight/sec-form-4-filed-by-jagpal-sukhi-3101737)
- 2022-07-01 20:41 UTC [SEC Form 4] [SEC Form 4 filed by Pelzer Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-pelzer-robert-3101721)
- 2022-07-01 20:39 UTC [SEC Form 4] [SEC Form 4 filed by Cooper Jeffrey H](https://www.quantisnow.com/insight/sec-form-4-filed-by-cooper-jeffrey-h-3101701)
- 2022-07-01 20:38 UTC [SEC Form 4] [SEC Form 4: Allen Andrew R returned $90,750 worth of shares to the company (1,650 units at $55.00), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-allen-andrew-r-returned-90750-worth-of-3101687)
- 2022-07-01 20:37 UTC [SEC Form 4] [SEC Form 4: Collard Craig A returned $742,500 worth of shares to the company (13,500 units at $55.00), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-collard-craig-a-returned-742500-worth-of-3101675)
- 2022-07-01 20:35 UTC [SEC Form 4] [SEC Form 4: Dilly Stephen George returned $275,000 worth of shares to the company (5,000 units at $55.00), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-dilly-stephen-george-returned-275000-worth-of-3101663)
- 2022-07-01 20:34 UTC [SEC Form 4] [SEC Form 4 filed by Thomson Mary Christina](https://www.quantisnow.com/insight/sec-form-4-filed-by-thomson-mary-christina-3101640)
- 2022-07-01 20:32 UTC [SEC Form 4] [SEC Form 4 filed by Turner William D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-turner-william-d-3101621)
- 2022-07-01 20:28 UTC [SEC Form 4] [SEC Form 4 filed by Norrett Kevin](https://www.quantisnow.com/insight/sec-form-4-filed-by-norrett-kevin-3101502)
- 2022-07-01 20:27 UTC [SEC Form 4] [SEC Form 4 filed by Oliger Christy J.](https://www.quantisnow.com/insight/sec-form-4-filed-by-oliger-christy-j-3101491)
- 2022-07-01 20:25 UTC [SEC Form 4] [SEC Form 4 filed by Erbez Georgia](https://www.quantisnow.com/insight/sec-form-4-filed-by-erbez-georgia-3101477)
- 2022-07-01 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101429)
- 2022-07-01 20:18 UTC [SEC Form POS AM filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-sierra-oncology-inc-3101373)
- 2022-07-01 20:17 UTC [SEC Form POS AM filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-sierra-oncology-inc-3101358)
- 2022-07-01 20:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101303)
- 2022-07-01 20:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101267)
- 2022-07-01 20:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101245)
- 2022-07-01 20:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101239)
- 2022-07-01 20:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101226)
- 2022-07-01 20:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101216)
- 2022-07-01 20:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101154)
- 2022-07-01 20:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101138)
- 2022-07-01 20:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Sierra Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-sierra-oncology-inc-3101101)
- 2022-07-01 20:02 UTC [SEC Form 8-K] [Sierra Oncology Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Changes in Control of Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sierra-oncology-inc-filed-sec-form-8-k-termination-of-a-3101042)
- 2022-06-29 20:14 UTC [SEC Form 8-K] [Sierra Oncology Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/sierra-oncology-inc-filed-sec-form-8-k-submission-of-matters-3090877)
- 2022-06-22 21:07 UTC [SEC Form 8-K] [Sierra Oncology Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/sierra-oncology-inc-filed-sec-form-8-k-other-events-3059572)
- 2022-06-17 20:17 UTC [SEC Form 4] [SEC Form 4 filed by Turner William D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-turner-william-d-3044419)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SRRA
- Earnings history: https://www.quantisnow.com/earnings/SRRA
- Dividend history: https://www.quantisnow.com/dividends/SRRA
- Insider transactions: https://www.quantisnow.com/insiders/SRRA
- Options chain: https://www.quantisnow.com/options/SRRA
- SEC 8-K filings only: https://www.quantisnow.com/company/SRRA/8-k
- RSS and alerts for SRRA: https://www.quantisnow.com/docs/rss-feeds.md
